Pilar Vicente

Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study

Miguel Nogué, Antonieta Salud, Pilar Vicente et al. · The Oncologist · 2011 · 154 citations · Full text

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer

Miguel J. Sotelo, Javier Sastre, M.L. Maestro et al. · Annals of Oncology · 2014 · 77 citations · Full text

Prognostic Marker, Prognostic Biomarkers, Surgical Oncology +10

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

Joaquim Bellmunt, Joan Albanell, Óscar Gallego et al. · Cancer · 1992 · 50 citations

Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

J. M. Roca, Vicente Alonso, Carles Pericay et al. · Chemotherapy · 2010 · 22 citations

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study

Jaime Feliú, Mónica Jorge Fernández, Teresa Macarulla et al. · Cancer Chemotherapy and Pharmacology · 2021 · 17 citations

Urology, Oncology, Pancreatic Cancer +7